To evaluate the role that MR Spectroscopy and MR Perfusion play in characterizing breast masses on MR Mammograms with HPE correlation.

Motivation: To evaluate the role that MR Spectroscopy and MR Perfusion play in characterizing breast masses on MR Mammograms with HPE correlation. Goal(s): To compare the findings of the Histopathological Evaluation (HPE) with the radiological diagnosis. To evaluate the role that MR Spectroscopy and MR Perfusion play in the identification of breast masses.Approach: 160 patients were included in prospective research design for eight months. Patients with k/c/o carcinoma, sono-mammography, post-operative evaluation, and screening mammography were included. Results: MRI diagnosis and histopathological results correlated in 86.1% patients. Dynamic Contrast Enhanced MR perfusion kinetics have been highly sensitive in distinguishing benign and malignant lesions. Impact: MR mammography has been demonstrated that MR Perfusion is extremely sensitive in identifying benign from malignant breast lesions. In order to provide sufficient information to differentiate between breast tumors, MR Spectroscopy has proven useful adjunct to MR Perfusion.